As 2026 progresses, the minimally invasive medical device market continues to evolve at a rapid pace. Growing procedural demand, increasing device complexity, and advances in materials science are driving a new era of innovation across the industry.
While many developments have influenced the market this year, three trends stand out for their potential to shape device design and manufacturing for years to come. These three trends include the continued rise of Nitinol, new approaches to catheter customization, and the increasing importance of secure, vertically integrated supply chains.
Nitinol Continues to Drive Innovation
Nitinol remains one of the most influential materials in minimally invasive device development. Its unique combination of shape memory and superelastic properties makes it ideal for navigating complex anatomy while delivering reliable mechanical performance.
One area where demand has accelerated is pulsed field ablation (PFA). As adoption of PFA technologies grows, device developers are increasingly relying on sophisticated electrode arrays and expandable catheter architectures that require:
Nitinol is uniquely suited to meet these challenges. Its ability to undergo significant deformation and return to a predetermined shape enables controlled deployment, consistent tissue contact, and long-term durability in demanding clinical environments.
At Confluent, Nitinol expertise extends far beyond component manufacturing. Through a highly controlled, vertically integrated supply chain, Confluent manages critical manufacturing processes from melt through tubing production and precision laser processing. This level of control helps OEMs reduce risk, improve consistency, and accelerate development timelines.
As next-generation cardiovascular, structural heart, and electrophysiology devices continue to advance, Nitinol will remain a foundational material enabling innovation.
Custom Materials Are Redefining Catheter Design
For years, device developers were often forced to design around the limitations of standard tubing materials. Today, that paradigm is changing.
As minimally invasive devices become increasingly complex, catheter shafts and delivery systems must achieve an unprecedented balance of flexibility, strength, durability, and precision. Rather than accepting off-the-shelf material properties, OEMs are increasingly seeking solutions tailored to their specific design requirements.
Filmcast Select™ was developed to address this need by giving engineers greater control over the material characteristics that directly impact device performance.
The program combines Confluent's materials science expertise with vertically integrated manufacturing capabilities, allowing customized tubing solutions to serve as the foundation for complete, high-performance device components.
Expanded Polyimide Options
Confluent's Filmcast Select™ portfolio includes four specialized polyimide formulations:
Each option can be further customized with PTFE additives or colorants, providing additional flexibility to optimize both performance and visibility.
Advanced PTFE Solutions
Filmcast Select™ also includes specialized PTFE tubing options designed to address specific performance requirements:
In addition, PTFE solutions can be manufactured using customer-preferred dispersions, helping OEMs leverage existing biocompatibility data and potentially simplify regulatory pathways.
The result is a more strategic approach to catheter design, where materials are selected to achieve performance goals rather than forcing design compromises.
Supply Chain Security Remains a Strategic Priority
While innovation continues to push device performance forward, supply chain resilience remains equally important.
Medical device outsourcing has evolved significantly in recent years. OEMs are no longer looking for suppliers that simply perform individual manufacturing steps. Instead, they are seeking strategic partners capable of supporting complex programs from development through commercialization.
This shift reflects increasing product complexity, tighter development timelines, and greater pressure to manage quality and regulatory requirements efficiently.
Vertically integrated manufacturing has become a key differentiator in this environment. When critical capabilities are consolidated within a single organization, OEMs benefit from:
At Confluent, vertical integration brings together advanced materials expertise, component manufacturing, assembly capabilities, and engineering support under one roof. This comprehensive approach helps OEMs accelerate development while maintaining confidence in quality, scalability, and supply continuity.
Partner with Confluent to Bring Your Next Device to Market
As minimally invasive devices continue to advance, success increasingly depends on the right combination of materials expertise, manufacturing capabilities, and supply chain reliability. Whether you're developing a next-generation PFA catheter, optimizing a delivery system, or scaling a complex device platform, Confluent Medical Technologies provides the technical expertise and vertically integrated solutions needed to move from concept to commercialization with confidence.
Ready to accelerate your next innovation? Connect with Confluent's team of materials science and manufacturing experts to explore how our Nitinol, catheter, and advanced component solutions can help bring your device to market faster.